Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Mesto bisfosfonatov pri zdravljenju bolnikov z rakom
Authors:ID Borštnar, Simona (Author)
Files:.pdf PDF - Presentation file, download (278,46 KB)
MD5: D7D2FACBA6717AE80E2F14717E90CFB8
PID: 20.500.12556/dirros/a104f4b3-80e5-4f94-a578-8ead6e252331
 
Language:Slovenian
Typology:1.01 - Original Scientific Article
Organization:Logo OI - Institute of Oncology
Abstract:Pri bolnikih z rakom in zasevki v kosteh je veliko tveganje za razvoj zapletov v kosteh, kar vodi v razvoj bolečin, patoloških zlomov, kompresije spinalnega kanala, hiperkalcemije in napredujoče nepokretnosti, zaradi česar se slabša kakovost življenja. Bisfosfonati preprečijo, zmanjšajo in odložijo te zaplete. Zaradi uvedbe teh zdravil so zapleti med bolniki z zasevki v kosteh bistveno redkejši. Znanih je tudi čedalje več izsledkov, ki kažejo na vlogo bisfosfonatov v preprečevanju izgube kostne mase med zdravljenjem raka. Danes poznamo vrsto bisfosfonatov, ki se razlikujejo po moči, učinkovitosti, odmerjanju, načinu dajanja in po odobrenih indikacijah za zdravljenje.
Keywords:bisfosfonati, hiperkalcemija, kostni zasevki, kosti, novotvorbe, metastaze
Publication status:Published
Publication version:Version of Record
Year of publishing:2008
Number of pages:str. 108-113
Numbering:Letn. 12, št. 2
PID:20.500.12556/DiRROS-8703 New window
UDC:616-006
ISSN on article:1408-1741
URN:URN:NBN:SI:doc-IOM7DF6R
COBISS.SI-ID:702075 New window
Copyright:by Authors
Publication date in DiRROS:31.08.2018
Views:3043
Downloads:852
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Onkologija. strokovni časopis za zdravnike
Shortened title:Onkologija
Publisher:Onkološki inštitut
ISSN:1408-1741
COBISS.SI-ID:65324032 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:Undetermined
Title:Biphosphonates in the Treatment of Breast Cancer Patients
Abstract:Cancer patients suffering from bone metastases are at increased risk for skeletal complications, which contributes to increased morbidity and have a negative effect on patients' quality of life. Bisphosphonates prevent, reduce, and delay cancer-related skeletal complications in patients, and have substantially decreased the prevalence of such events since their introduction. In addition, the results of clinical trials investigating the efficacy of bisphosphonates in cancer-treatment bone loss have been recently published. Today, a broad range of bisphosphonates with differences in potency, efficacy, dosing, and administration as well as approved indications is available.


Archive

niGradiv

Back